Targeting the EphB4 receptor tyrosine kinase sensitizes HER2-positive breast cancer cells to Lapatinib.
Ding J, Yao Y, Huang G, Wang X, Yi J, Zhang N, Liu C, Wang K, Zhang Y, Wang M, Liu P, Ye M, Li M, Cheng H.
Ding J, et al. Among authors: yi j.
Cancer Lett. 2020 Apr 10;475:53-64. doi: 10.1016/j.canlet.2020.01.032. Epub 2020 Jan 29.
Cancer Lett. 2020.
PMID: 32006616
Free article.